BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang C, Hu Y, Gao J, Jiang J, Shi S, Wang J, Geng Q, Liang X, Chai X. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci 2020;257:118004. [PMID: 32621918 DOI: 10.1016/j.lfs.2020.118004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Guan X, Zhou W, Li L, Peng Q. Dexmedetomidine Alleviates Hypoxic-Ischemic Brain Damage in Neonatal Rats Through Reducing MicroRNA-134-5p-Mediated NLRX1 Downregulation. Journal of Stroke and Cerebrovascular Diseases 2022;31:106411. [DOI: 10.1016/j.jstrokecerebrovasdis.2022.106411] [Reference Citation Analysis]
2 Liu Q, Wu J, Lai S, Li G. MiR-665 Participates in the Protective Effect of Dexmedetomidine in Ischemic Stroke by ROCK2/NF-κB Axis. Neurochem Res 2022. [PMID: 35538293 DOI: 10.1007/s11064-022-03597-x] [Reference Citation Analysis]
3 Song L, Feng S, Yu H, Shi S. Dexmedetomidine Protects Against Kidney Fibrosis in Diabetic Mice by Targeting miR-101-3p-Mediated EndMT. Dose-Response 2022;20:155932582210834. [DOI: 10.1177/15593258221083486] [Reference Citation Analysis]
4 Lu C, Guo X, He X, Chang Y, Zheng F, Xu C, Zhang S, Zhou Y, Li J. Cardioprotective effects of Sinomenine in myocardial ischemia/reperfusion injury in a rat model. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.04.005] [Reference Citation Analysis]
5 Li YJ, Zhang DZ, Xi Y, Wu CA. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134. Hum Exp Toxicol 2021;:9603271211023784. [PMID: 34121490 DOI: 10.1177/09603271211023784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Li G, LeiQian, Gu P, Fan D. Dexmedetomidine post-conditioning attenuates cerebral ischemia following asphyxia cardiac arrest through down-regulation of apoptosis and neuroinflammation in rats. BMC Anesthesiol 2021;21:180. [PMID: 34182937 DOI: 10.1186/s12871-021-01394-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang L, Wang S, Jia T, Sun X, Xing Z, Liu H, Yao J, Chen Y. Dexmedetomidine prevents cardiomyocytes from hypoxia/reoxygenation injury via modulating tetmethylcytosine dioxygenase 1-mediated DNA demethylation of Sirtuin1. Bioengineered 2022;13:9369-86. [PMID: 35387565 DOI: 10.1080/21655979.2022.2054762] [Reference Citation Analysis]
8 Huang X, Hou R, Pan W, Wu D, Zhao W, Li Q. A functional polysaccharide from Eriobotrya japonica relieves myocardial ischemia injury via anti-oxidative and anti-inflammatory effects. Food Funct 2021. [PMID: 34878451 DOI: 10.1039/d1fo03208a] [Reference Citation Analysis]
9 Zheng X, Li J, Fan Q, Zhao X, Chen K. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis. Int J Cardiol 2021;338:185-95. [PMID: 33731281 DOI: 10.1016/j.ijcard.2021.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Gao F, Zhao Y, Zhang B, Xiao C, Sun Z, Gao Y, Dou X. Mitochondrial targeted astaxanthin liposomes for myocardial ischemia-reperfusion injury based on oxidative stress. J Biomater Appl. [DOI: 10.1177/08853282221087102] [Reference Citation Analysis]
11 Liu B, Deng Q, Zhang L, Zhu W. Nobiletin alleviates ischemia/reperfusion injury in the kidney by activating PI3K/AKT pathway. Mol Med Rep 2020;22:4655-62. [PMID: 33173956 DOI: 10.3892/mmr.2020.11554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Liu X, Zhang J, Xie W. The role of ferroptosis in acute lung injury. Mol Cell Biochem 2022. [PMID: 35166985 DOI: 10.1007/s11010-021-04327-7] [Reference Citation Analysis]
13 Paskeh MDA, Asadi A, Mirzaei S, Hashemi M, Entezari M, Raesi R, Hushmandi K, Zarrabi A, Ertas YN, Aref AR, Samarghandian S, Reiter RJ, Ren J. Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110323] [Reference Citation Analysis]
14 Liu Z, Jin Y, Feng C, Liu G, Wang Y, Zhao X, Liu G, Khalaf OI. Renoprotective Effect of Intraoperative Dexmedetomidine in Renal Transplantation. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/9275406] [Reference Citation Analysis]
15 Tang C, Hong J, Hu C, Huang C, Gao J, Huang J, Wang D, Geng Q, Dong Y. Palmatine Protects against Cerebral Ischemia/Reperfusion Injury by Activation of the AMPK/Nrf2 Pathway. Oxid Med Cell Longev 2021;2021:6660193. [PMID: 33777318 DOI: 10.1155/2021/6660193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yu H, Jiang G, Hu W, Xu C. Pin1 aggravates renal injury induced by ischemia and reperfusion in rats via Nrf2/HO-1 mediated endoplasmic reticulum stress. Acta Cir Bras 2022;37:e370101. [PMID: 35416857 DOI: 10.1590/acb370101] [Reference Citation Analysis]